Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Feb 18, 2022
PPTA Leadership Update – Amy Efantis
Dear PPTA Members and Patient Stakeholders, We are writing to you today to inform you that Amy Efantis, PPTA’s president & CEO, recently informed the Global Board of Directors of her decision to leave the association.
All
PPTA statements
Feb 18, 2022
PPTA Leadership Update – Amy Efantis
Dear PPTA Members and Patient Stakeholders, We are writing to you today to inform you that Amy Efantis, PPTA’s president & CEO, recently informed the Global Board of Directors of her decision to leave the association.
All
PPTA statements
Feb 16, 2022
PPTA Disagrees with Ruling from Romanian Competition Council
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax.
All
PPTA statements
Feb 16, 2022
PPTA Disagrees with Ruling from Romanian Competition Council
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax.
All
PPTA statements
Jan 1, 2022
2021 Annual Report
2021 Annual Report
All
PPTA Annual report
https://prezi.com/view/e2n8YKTCNdUS3BNcasJw/
Jan 1, 2022
2021 Annual Report
2021 Annual Report
All
PPTA Annual report
https://prezi.com/view/e2n8YKTCNdUS3BNcasJw/
Dec 17, 2021
A missed opportunity to acknowledge EU’s dependency on U.S. plasma
December 17, 2021 (Brussels, Belgium) — The Plasma Protein Therapeutics Association (PPTA) regrets that the publication of the European Commission report, “Study on medicine shortages,” does not include plasma, which is a biological starting material for the manufacture of lifesaving plasma-derived medicinal products (PDMPs).
All
Press releases
Dec 17, 2021
A missed opportunity to acknowledge EU’s dependency on U.S. plasma
December 17, 2021 (Brussels, Belgium) — The Plasma Protein Therapeutics Association (PPTA) regrets that the publication of the European Commission report, “Study on medicine shortages,” does not include plasma, which is a biological starting material for the manufacture of lifesaving plasma-derived medicinal products (PDMPs).
All
Press releases
No results found